Renue Lifesciences Pioneering the Future of Cellular Health
Renue is a therapeutic platform that harnesses the regenerative potential of reprogramming factors (Yamanaka factors, OSKL, etc) as well as small molecules to rejuvenate cells and tag damaged cells for debris removal. Renue therapeutics employs partial reprogramming to derive rejuvenated versions of target cell types and tissues.
Problem:
80% of adults 65+ live with at least one incurable chronic disease.
Need:
Go beyond symptom management to restore cellular health.
Solution:
AI-guided reprogramming therapeutics that reverse or halt disease at its biological root.
Problem:
Drug development takes 10–15 years and over $2.6B with 90% failure rates.
Need:
Faster, smarter ways to design adaptive therapies.
Solution:
AI-native platform accelerating discovery and precision design of next-gen medicines.
Problem:
Aging and complex diseases damage cells the body can’t repair.
Need:
Safe, targeted rejuvenation of tissues and organs.
Solution:
Partial cellular reprogramming to restore and renew function without altering identity.
1.Modular approach for customizable, cohesive solutions
2.Automated workflows and claims processing
3.Reduced administrative complexity
4.Unified care delivery across systems
5.High security and compliance standards
6.Supports healthcare providers in optimizing care delivery and patient outcomes